Study of Latiglutenase in T1D/CD Patients
Clinical trial NCT04839575 · TERMINATED
Trial details
- NCT number
- NCT04839575
- Sponsor
- Entero Therapeutics
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-06
- Primary completion
- 2022-12-19
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.